683 Capital Management, LLC Fennec Pharmaceuticals Inc. Transaction History

683 Capital Management, LLC

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	SELL	$8.82 - $11.12 $810,487 - $1.02 Million	-91,892 Reduced 65.64%	48,108 $534,000
Q4 2023 Feb 14, 2024	SELL	$6.48 - $11.61 $1.04 Million - $1.86 Million	-160,000 Reduced 53.33%	140,000 $1.57 Million
Q4 2022 Feb 14, 2023	SELL	$7.63 - $10.22 $647,207 - $866,901	-84,824 Reduced 22.04%	300,000 $2.88 Million
Q3 2022 Nov 14, 2022	SELL	$5.71 - $8.54 $231,334 - $345,989	-40,514 Reduced 9.53%	384,824 $3.12 Million
Q2 2022 Aug 15, 2022	SELL	$5.17 - $6.33 $304,926 - $373,343	-58,980 Reduced 12.18%	425,338 $2.37 Million
Q1 2022 May 16, 2022	SELL	$4.29 - $6.08 $965,172 - $1.37 Million	-224,982 Reduced 31.72%	484,318 $2.71 Million
Q4 2021 Feb 14, 2022	SELL	$3.89 - $10.01 $1.56 Million - $4.01 Million	-400,700 Reduced 36.1%	709,300 $3.12 Million
Q2 2020 Aug 14, 2020	BUY	$5.43 - $9.39 $868,800 - $1.5 Million	160,000 Added 16.84%	1,110,000 $9.27 Million
Q4 2019 Feb 14, 2020	SELL	$4.25 - $6.49 $90,741 - $138,567	-21,351 Reduced 2.2%	950,000 $6.17 Million
Q3 2018 Nov 14, 2018	BUY	$7.84 - $10.83 $816,661 - $1.13 Million	104,166 Added 12.01%	971,351 $7.97 Million
Q4 2017 Feb 14, 2018	BUY	$8.9 - $12.35 $523,498 - $726,427	58,820 Added 7.28%	867,185 $8.69 Million
Q3 2017 Nov 14, 2017	BUY	$11.09 - $12.0 $8.96 Million - $9.7 Million	808,365	808,365 $8.87 Million

14.3M

10K

83.8K

Ticker FENC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 26,067,300
Market Cap $136M
Description
Fennec Pharmaceuticals Inc. operates as a biopharmaceutical company. Its product candidate in the clinical stage of development is PEDMARK, a formulation of sodium thiosulfate for the prevention of platinum-induced ototoxicity in pediatric cancer patients. The company was formerly known as Adherex Technologies Inc. and changed its name to Fennec...

Get notified when there are updates to the investment portfolio of 683 Capital Management, LLC, based on Form 13F filings with the SEC.

Stay updated on 683 Capital Management, LLC with notifications on news.